tyrosine has been researched along with Carcinoma, Epidermoid in 126 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (16.67) | 18.7374 |
| 1990's | 38 (30.16) | 18.2507 |
| 2000's | 35 (27.78) | 29.6817 |
| 2010's | 28 (22.22) | 24.3611 |
| 2020's | 4 (3.17) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; He, Q; Li, J; Li, Y; Liu, F; Wei, W; Wu, M; Xiong, K; Zhang, B | 1 |
| Clark, LE; Dickinson, AJG; Lima, S | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chatterjee, A; Gowda, H; Jain, AP; Keshava Prasad, TS; Kumar, M; Mathur, PP; Nanjappa, V; Patel, K; Pinto, S; Radhakrishnan, A; Raja, R; Sidransky, D | 1 |
| Garapati, M; Prieto-Granada, CN | 1 |
| Chen, MC; Chiang, SL; Hua, CH; Ko, YC; Lee, CH; Lin, SH; Velmurugan, BK; Yeh, KT | 1 |
| Cardoso, SV; de Faria, PR; Loyola, AM; Silva Servato, JP; Ueira Vieira, C | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Miyashita, G; Miyazaki, H; Negishi, A; Tokue, A; Tominaga, H; Tsushima, Y; Yokoo, S | 1 |
| Delgado, M; do Amaral, B; Garcez, F; Lopes, C; Monteiro, L; Ricardo, S | 1 |
| Antonowicz, B; Dziemianczyk, D; Grabowska, SZ; Jablonska, E; Ratajczak-Wrona, W | 1 |
| Ramanathan, A; Tushar, MD | 1 |
| Altiok, S; Doshi, P; Fulp, W; Haura, EB; Sasser, K; Smith, MA; Song, L | 1 |
| Burger, IA; Dinkelborg, L; Friebe, M; Graham, K; Haerle, SK; Hany, TF; Horn-Tutic, M; Kowal, K; Luurtsema, G; Maas, B; Pruim, J; Schaefer, NG; Schibli, R; Stephens, A; von Schulthess, GK; Wiegers, J; Zitzmann-Kolbe, S | 1 |
| Beghini, M; Bibiano Borges, CR; de Araújo, MS; de Lima, LM; Miranda Alves, P; Muniz, JM; Napimoga, MH; Nogueira, RD; Pereira, SA; Rodrigues, DB; Rodrigues, V | 1 |
| De Maria, R; Duranti, E; Eramo, A; Fecchi, K; Gallo, E; Milella, M; Mottolese, M; Pilozzi, E; Policicchio, E; Salvati, V; Sette, G; Tartaglia, M; Visca, P | 1 |
| Chen, PT; Chiu, YW; Hsu, YK; Huang, CM; Liou, LY; Luo, FJ; Yuan, TC | 1 |
| Balermpas, P; Fokas, E; Helmke, C; Kitz, J; Martin, D; Matthess, Y; Raab, M; Rave-Fränk, M; Rödel, C; Rödel, F; Strebhardt, K; Wieland, U | 1 |
| Sylow, L | 1 |
| Yuan, TC | 1 |
| Cheng, J; Gao, X; Jin, H; Zheng, G | 1 |
| Avgoustidis, D; Gkouveris, I; Karanikou, M; Nikitakis, N; Rassidakis, G; Sklavounou, A | 1 |
| Fukumoto, D; Harada, N; Kakiuchi, T; Kamijo, A; Kawaguchi, AT; Murayama, C; Tsukada, H | 1 |
| Krabbe, CA; Pruim, J; Roodenburg, JL; van der Wal, JE; van der Werff-Regelink, G | 1 |
| Allameh, A; Nasseri-Moghaddam, S; Rasmi, Y; Sadreddini, M; Sharifi, R; Tavangar, SM | 1 |
| Imhof, D; Liebmann, C; Mertens, C; Valkova, C; Weisheit, S | 1 |
| Arisaka, Y; Endo, K; Hanaoka, H; Higuchi, T; Ishikita, T; Miyakubo, M; Miyashita, G; Morita, S; Nakasone, Y; Negishi, A; Oriuchi, N; Tominaga, H; Yokoo, S | 1 |
| Becker, A; Chiappori, A; Haura, EB; Sommers, E; Song, L | 1 |
| Dixon, KM; Halliday, GM; Mason, RS; Mohan, R; Norman, AW; Reeve, VE; Rybchyn, MS; Sequeira, VB | 1 |
| Du, Y; Gao, S; Hu, M; Lubet, RA; Szabo, E; Wang, Y; Wen, W; Yao, R; You, M | 1 |
| Pries, R; Riebe, C; Schroeder, KN; Wollenberg, B | 1 |
| Aquino, G; Botti, G; Bufo, P; Caraglia, M; Cozza, V; Cuda, G; De Rosa, A; Di Domenico, M; Florio, G; Franco, R; Grimaldi, A; Liguori, G; Lo Muzio, L; Longo, F; Losito, S; Mattoni, M; Pannone, G; Santoro, A; Sbordone, C; Serpico, R; Staibano, S | 1 |
| Asano, N; Endo, H; Iijima, K; Imatani, A; Koike, T; Kusaka, G; Shimosegawa, T; Uno, K | 1 |
| Aggarwal, BB; Gupta, SC; Phromnoi, K | 1 |
| Hu, Y; Li, J; Li, P; Li, Y; Liu, H; Wan, G; Wang, Z; Ye, J; Zhang, G | 1 |
| Albers, FW; Burlage, F; de Boer, JR; Krikke, A; Pruim, J; Que, TH; Tiebosch, AT; Vaalburg, W; van der Laan, BF; Willemsen, AT | 1 |
| Bertics, PJ; Dam, P; Kim, YN | 1 |
| Kanda, N; Watanabe, S | 2 |
| Kamatani, T; Osaki, T; Ueta, E; Yamamoto, T | 1 |
| Albers, FW; de Boer, JR; Pruim, J; Que, TH; Vaalburg, W; van der Laan, BF; Willemsen, AT | 1 |
| Ahn, BH; Chang, JS; Choi, KS; Jo, YH; Kim, EH; Kim, MS; Kim, SY; Kwon, TK; Lee, YH; Min, DS | 1 |
| Bagaeva, VV; Grudinkin, PS; Nikol'skiĭ, NN | 1 |
| Cheng, HY; Cook, RG; Shao, H; Tweardy, DJ | 1 |
| Albers, FW; Burlage, F; De Boer, JR; Krikke, A; Pruim, J; Tiebosch, AT; Vaalburg, W; Van Der Laan, BF | 1 |
| Chen, ZF; Guo, W; Jin, X; Kuang, G; Li, Y; Wang, N; Wang, R; Wang, SJ; Wei, LZ; Wen, DG; Zhang, JH | 1 |
| Getsios, S; Green, KJ; Klessner, J; Lorch, JH; Park, JK; Stack, MS; Wu, YL | 1 |
| Carpenter, WM; Huang, L; Kramer, RH; Lin, CS; Murai, M; Regezi, J; Shen, X; Silverman, S | 1 |
| Albers, FW; Burlage, F; de Boer, JR; Pruim, J; Vaalburg, W; van der Laan, BF | 1 |
| Bai, R; Dettin, LE; Glazer, RI; Kopelovich, L; Kopleovich, L; Kozikowski, AP; Russell, RG; Wei, ZL; Yin, Y | 1 |
| Acs, G; Cohen, N; Dalgard, C; Lai, SY; Lu, H; Mohyeldin, A; Verma, A | 1 |
| Chang, NS; Chao, SC; Chen, ST; Cheng, CL; Hsu, LJ; Lai, FJ; Lee, JY; Sheen, MC; Shen, CL; Sheu, HM; Wu, CH | 1 |
| Bruckner-Tuderman, L; Heino, J; Kainulainen, T; Nissinen, L; Parikka, M; Salo, T; Tasanen, K | 1 |
| Aoki, S; Cho, SH; Gao, JQ; Kobayashi, M; Kuwano, M; Kuwano, T; Mayumi, T; Nakagawa, S; Nakao, S; Ono, M; Shibuya, M | 1 |
| Merkulova, NA; Perova, AA; Sedova, VM; Solodovnikova, AS | 1 |
| Bette, M; Folz, BJ; Mandic, R; Neubauer, A; Rodgarkia-Dara, CJ; Weihe, E; Werner, JA; Zhu, L | 1 |
| Kong, SK; Kwok, TT; Tsang, WP | 1 |
| Brunton, VG; Frame, MC; Harrington, K; Hooper, S; Macpherson, IR; McGarry, L; Ozanne, BW; Sahai, E; Serrels, A | 1 |
| Dorosh, VN; Grudinkin, PS; Kropotov, AV; Nikolsky, NN; Zenin, VV | 1 |
| Frisch, SM; Helfer, B; Senft, J | 1 |
| di Spilimbergo, SS; Padula, E; Penzo, M; Rampazzo, A; Squaquara, R | 1 |
| Cohen, S; Erneux, C; Garbers, DL | 1 |
| Cohen, S; Ushiro, H | 1 |
| Bornstein, P; Brautigan, DL; Gallis, B | 1 |
| Erikson, RL; Shealy, DJ | 1 |
| Bornstein, P; Casnellie, JE; Gallis, B; Krebs, EG; Pike, LJ | 1 |
| Cohen, S | 1 |
| Casnellie, JE; Edelman, AM; Gallis, B; Krebs, EG | 1 |
| King, AC; Moon, SO; Palfrey, HC | 1 |
| Connors, JM; Frackelton, AR; Friedman, B; Fujiki, H; Rosner, MR; Ross, AH; Sugimura, T | 1 |
| Bornstein, P; Casnellie, JE; Gallis, B; Krebs, EG; Marquardt, H; Pike, LJ; Todaro, GJ | 1 |
| Hakomori, S; Igarashi, Y; Kitamura, K; Zhou, Q | 1 |
| Daya-Makin, M; Hogg, JC; Lipp, M; Mogentale, TL; Parchomchuk, J; Pelech, SL; Sanghera, JS | 1 |
| Kramer, RH; Matsumoto, K; Nakamura, T | 1 |
| Doki, Y; Inoue, M; Iwazawa, T; Kadowaki, T; Matsui, S; Oka, H; Shimaya, K; Shiozaki, H; Takeichi, M; Tamura, S | 1 |
| Jia, XS; Sun, AJ; Zhang, DR | 1 |
| Cantey, JR; Dytoc, MT; Ismaili, A; Philpott, DJ; Sherman, PM | 1 |
| Anderson, JM; Balda, MS; Van Itallie, CM | 1 |
| Katoh, I; Kyushiki, H; Sakamoto, Y; Yoshinaka, Y | 1 |
| Feghali, CA; Wright, TM | 1 |
| Campbell, DL; Carbonaro-Hall, D; Hall, F; Pelech, S; Sanghera, J; Warburton, D; Williams, R; Wu, F | 1 |
| Cardinali, M; Ensley, JF; Pietraszkiewicz, H; Robbins, KC | 1 |
| Burova, EB; Nesterov, AM; Nikol'skiĭ, NN; Vdovina, IB | 1 |
| Wen, ZD; Yang, SD; Yu, JS | 1 |
| Fujii, K; Furukawa, F; Matsuyoshi, N | 1 |
| Braams, JW; Nikkels, PG; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Kasid, U; Patel, BK; Ray, S; Whiteside, TL | 1 |
| Burova, EB; Chupreta, SV; Nikol'skył, NN; Vasilenko, KP | 1 |
| Aoto, M; Fukami, Y; Gotoh, N; Kakumoto, M; Otsuki, T; Sato, K; Shibuya, M; Tokmakov, AA | 1 |
| Epstein, RJ; Gulliford, TJ; Huang, GC; Ouyang, X | 1 |
| Burgaud, JL; Fehrentz, JA; Martinez, J; Nahon, JL; Poosti, R | 1 |
| Kuan, CY; Lee, SC; Wen, ZD; Yang, SD | 1 |
| Affleck, K; Dean, C; Modjtahedi, H; Stubberfield, C | 1 |
| Braams, JW; Nikkels, PG; Nooren, CA; Roodenburg, JL; Vaalburg, W; Vermey, A; Witjes, MJ | 1 |
| Akiyoshi, T; Mafune, K; Mori, M; Sugimachi, K; Tanaka, S; Tanaka, Y; Wands, JR | 1 |
| Birembault, P; Nawrocki, B; Polette, M; Tournier, JM; Van Hengel, J; Van Roy, F | 1 |
| Akinaga, S; Akiyama, T; Okabe, M; Shimizu, M; Tamaoki, T | 1 |
| Bowers, G; Dent, P; Logsdon, C; Park, JS; Reardon, DB; Schmidt-Ullrich, R; Valerie, K | 1 |
| Blinder, L; Chong, AS; Huang, W; Mall, JW; Myers, JA; Saclarides, TJ; Shen, J; Williams, JW; Xu, X | 1 |
| Bianchi, PC; Joubert, AM; Joubert, F; Lottering, ML; Panzer, A; Seegers, JC | 1 |
| Bentz, BG; Haines, GK; Radosevich, JA | 2 |
| Fukai, Y; Kato, H; Kuwano, H; Masuda, N; Miyazaki, T; Nakajima, M; Nakajima, T; Tajima, K; Tsukada, K; Tsutsumi, S; Yoshikawa, M | 1 |
| Ahn, BH; Jo, YH; Min, DS | 1 |
| Ishibashi, T; Nishio, M; Yoshida, J | 1 |
| Chuang, Y; Chung, DC; Kirley, SD; Wu, CL; Xiao, H; Zukerberg, LR | 1 |
| Etemad-Moghadam, G; Hainaut, P; Kamangar, F; Martel-Planche, G; Rastgar-Jazii, F; Saidi, F; Sepehr, A; Tanière, P; Yazdanbod, M; Zia'ee, AA | 1 |
| Moolenaar, WH; Ploegh, HL; Verheijden, GF | 1 |
| Brock, T; Kahn, CR; Karasik, A; Pepinsky, RB; Reddy, SS | 1 |
| Nesterov, A; Nikolsky, N; Reshetnikova, G; Vinogradova, N | 1 |
| Nesterov, AM; Nikol'skiĭ, NN; Reshetnikova, GF; Sorkin, AD; Vinogradova, NA | 1 |
| Kan, M; Kayada, Y; Myoken, Y; Okamoto, T; Sato, GH; Sato, JD | 1 |
| Kornilova, ES; Nesterov, AM; Nikol'skiĭ, NN; Vdovina, IB | 1 |
| Dressler, KA; Goldkorn, T; Kolesnick, RN; Liotta, D; Menaldino, D; Mendelsohn, J; Muindi, J; Radin, NS | 1 |
| Duś, D; Kafarski, P; Lejczak, B | 1 |
| Hirai, M; Kobayashi, M; Shimizu, N | 1 |
| Evans, RM; Gamou, S; Gill, GN; Lin, C; Rosenfeld, MG; Shimizu, N; Thompson, DM; Weber, W | 1 |
| Landreth, GE; Rieser, GD; Williams, LK | 1 |
| Bremer, EG; Hakomori, S; Schlessinger, J | 1 |
| Cooper, JA; King, CS; Moss, B; Twardzik, DR | 1 |
| Izumi, T; Kadowaki, T; Kasuga, M; Koyasu, S; Nishida, E; Sakai, H; Takaku, F; Tobe, K; Yahara, I | 1 |
| Carpenter, G; Daniel, TO; Wahl, MI | 1 |
| Akiyama, T; Kadooka, T; Ogawara, H | 1 |
| Alberghina, L; Comoglio, PM; Morello, L; Sturani, E; Toschi, L; Zippel, R | 1 |
| Dogliotti, M | 1 |
| Farbiszewski, R; Rzeczycki, W; Worowski, K | 1 |
| Anke, A; Heilmann, HH; Knapp, A; Machill, G; Schwenke, W | 1 |
1 review(s) available for tyrosine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
3 trial(s) available for tyrosine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tyrosine | 2010 |
¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2010 |
123 other study(ies) available for tyrosine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Alteration of intestinal microecology by oral antibiotics promotes oral squamous cell carcinoma development.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Glutamates; Head and Neck Neoplasms; Mice; Mouth Neoplasms; Protein Kinases; Receptor-Interacting Protein Serine-Threonine Kinases; Squamous Cell Carcinoma of Head and Neck; Tyrosine | 2022 |
GBA Regulates EMT/MET and Chemoresistance in Squamous Cell Carcinoma Cells by Modulating the Cellular Glycosphingolipid Profile.
Topics: Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Glycosphingolipids; Humans; Signal Transduction; Tyrosine | 2023 |
How to Achieve Therapeutic Response in Erlotinib-Resistant Head and Neck Squamous Cell Carcinoma? New Insights from Stable Isotope Labeling with Amino Acids in Cell Culture-Based Quantitative Tyrosine Phosphoproteomics.
Topics: Amino Acids; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Isotope Labeling; Protein Kinase Inhibitors; Squamous Cell Carcinoma of Head and Neck; Tyrosine | 2021 |
Cutaneous Mixed Tumor and Recurrent Laryngeal Squamous Cell Carcinoma With Tyrosine-Rich Crystalloids: The Good, the Bad, and the Pretty.
Topics: Adenoma, Pleomorphic; Adult; Aged; Carcinoma, Squamous Cell; Crystalloid Solutions; Female; Head and Neck Neoplasms; Humans; Isotonic Solutions; Laryngeal Neoplasms; Male; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; Sweat Gland Neoplasms; Tyrosine | 2017 |
PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Female; Fingolimod Hydrochloride; Glycogen Synthase Kinase 3 beta; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Phosphorylation; Proportional Hazards Models; Protein Phosphatase 2; Risk Factors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tyrosine | 2018 |
The importance of inducible nitric oxide synthase and nitrotyrosine as prognostic markers for oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Humans; Leukoplakia, Oral; Mouth Neoplasms; Nitric Oxide; Nitric Oxide Synthase Type II; Prognosis; Signal Transduction; Tyrosine | 2019 |
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Topics: Aged; Aged, 80 and over; Bone Marrow Neoplasms; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2013 |
Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; ErbB Receptors; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Phosphorylation; Prognosis; Retrospective Studies; Survival Rate; Tyrosine | 2014 |
Levels of biological markers of nitric oxide in serum of patients with squamous cell carcinoma of the oral cavity.
Topics: Aged; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Mouth Neoplasms; Nitric Oxide; Statistics, Nonparametric; Tyrosine | 2013 |
Tyrosine 1045 codon mutations in exon 27 of EGFR are infrequent in oral squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Codon; Cross-Sectional Studies; DNA, Neoplasm; ErbB Receptors; Exons; Humans; Mouth Neoplasms; Mutation; Polymerase Chain Reaction; Prognosis; Tyrosine | 2013 |
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Erlotinib Hydrochloride; Female; Fibroblasts; Humans; Interleukin-6; Lung Neoplasms; Mice; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Quinazolines; ras Proteins; Serine; STAT3 Transcription Factor; Tyrosine | 2014 |
First clinical results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Inflammation; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2014 |
Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Topics: Benzamides; Biomarkers, Tumor; Carcinoma, Squamous Cell; Diagnosis, Differential; Galectin 3; Galectins; Humans; Immunohistochemistry; Leukoplakia; Lichen Planus; Mast Cells; Matrix Metalloproteinase 3; Mouth Neoplasms; Tyrosine | 2015 |
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Pharmacological; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Evaluation, Preclinical; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Middle Aged; Neoplasm Staging; Neoplastic Stem Cells; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Signal Transduction; Tyrosine; Xenograft Model Antitumor Assays | 2015 |
Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cortactin; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mouth Neoplasms; Neoplasm Invasiveness; Phosphorylation; Precancerous Conditions; rac1 GTP-Binding Protein; Tyrosine | 2016 |
Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Caspase 8; Chemoradiotherapy; DNA, Viral; Female; Fluorouracil; Human papillomavirus 16; Humans; Male; Middle Aged; Mitomycin; Papillomavirus Infections; Phosphorylation; Prognosis; Protein Serine-Threonine Kinases; Survival Analysis; Tumor Suppressor Proteins; Tyrosine | 2016 |
Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mouth Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Tyrosine | 2016 |
Response to: Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mouth Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Tyrosine | 2016 |
Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Chromatography, High Pressure Liquid; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Metabolomics; Middle Aged; ROC Curve; Tandem Mass Spectrometry; Tyrosine | 2017 |
ERK1/2, JNK and STAT3 activation and correlation with tumor differentiation in oral SCC.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Differentiation; Female; Humans; Immunohistochemistry; Male; MAP Kinase Signaling System; Middle Aged; Mitogen-Activated Protein Kinases; Mouth Neoplasms; Neoplasm Grading; Phosphorylation; Serine; STAT3 Transcription Factor; Tyrosine | 2017 |
Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Methionine; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Positron-Emission Tomography; Tyrosine | 2009 |
Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Barrett Esophagus; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2; Disease Progression; Esophageal Neoplasms; Esophagus; Female; Gastroesophageal Reflux; Glutathione S-Transferase pi; Humans; Immunohistochemistry; Iran; Male; Middle Aged; Precancerous Conditions; Tumor Suppressor Protein p53; Tyrosine; Young Adult | 2009 |
Activation by tyrosine phosphorylation as a prerequisite for protein kinase Cζ to mediate epidermal growth factor receptor signaling to ERK.
Topics: Animals; Carcinoma, Squamous Cell; Catalytic Domain; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Enzyme Activation; ErbB Receptors; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Kinase C; Signal Transduction; Tyrosine | 2010 |
A pilot study of preoperative gefitinib for early-stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gefitinib; Humans; Lung Neoplasms; Male; Neoplasm Staging; Phosphorylation; Pilot Projects; Prognosis; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; STAT3 Transcription Factor; Survival Rate; Tissue Distribution; Tyrosine | 2010 |
1α,25(OH)₂-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Calcitriol; Carcinoma, Squamous Cell; Cell Line; Humans; Immunosuppressive Agents; Mice; Receptors, Calcitriol; Signal Transduction; Skin Neoplasms; Tumor Suppressor Protein p53; Tyrosine; Ultraviolet Rays | 2011 |
Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzoxepins; Biomarkers; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; Chemoprevention; Drugs, Chinese Herbal; ErbB Receptors; Limonins; Male; Matrines; Mice; Mouth Neoplasms; Phosphorylation; Pterocarpans; Quinolizines; Tyrosine | 2013 |
Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway.
Topics: Carcinoma, Squamous Cell; Down-Regulation; Head and Neck Neoplasms; Humans; Interleukin-6; Interleukin-8; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RNA, Small Interfering; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2011 |
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; ErbB Receptors; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Paraffin Embedding; Phosphorylation; Prognosis; Retrospective Studies; Tissue Array Analysis; Tyrosine | 2012 |
The role of nitric oxide in the induction of caudal-type homeobox 2 through epidermal growth factor receptor in the development of Barrett's esophagus.
Topics: Barrett Esophagus; Carcinoma, Squamous Cell; CDX2 Transcription Factor; Cell Line, Tumor; Epithelium; ErbB Receptors; Esophagogastric Junction; Homeodomain Proteins; Humans; Immunohistochemistry; Metaplasia; Nitric Oxide; Phosphorylation; Tyrosine | 2012 |
Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Activation; Flavonoids; Head and Neck Neoplasms; Humans; Multiple Myeloma; Neovascularization, Pathologic; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA, Small Interfering; STAT3 Transcription Factor; Structure-Activity Relationship; Tyrosine | 2013 |
The clinical implication of tumoral Gal-1 expression in laryngeal squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Carcinoma, Squamous Cell; Female; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Tyrosine | 2013 |
Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Feasibility Studies; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Tomography, Emission-Computed; Tyrosine | 2002 |
Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation.
Topics: Androstadienes; Carcinoma, Squamous Cell; Caveolae; Caveolin 1; Caveolins; Cell Line; Chromones; Colchicine; Cyclodextrins; Cytochalasin D; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Flavonoids; Humans; Kinetics; Morpholines; Nucleic Acid Synthesis Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; src-Family Kinases; Tumor Cells, Cultured; Tyrosine; Wortmannin | 2002 |
Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
Topics: Carcinoma, Squamous Cell; Chemokine CXCL10; Chemokines, CXC; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression; Humans; Interferon-Stimulated Gene Factor 3; Isoenzymes; Janus Kinase 1; Janus Kinase 2; Membrane Proteins; Nitrobenzenes; Phosphorylation; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Prostaglandin E; Response Elements; RNA, Messenger; Signal Transduction; Skin Neoplasms; Sulfonamides; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine | 2002 |
Histamine inhibits the production of interferon-induced protein of 10 kDa in human squamous cell carcinoma and melanoma.
Topics: Carcinoma, Squamous Cell; Chemokine CXCL10; Chemokines, CXC; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation, Neoplastic; Histamine; Humans; Interferon-gamma; Interferon-Stimulated Gene Factor 3; Janus Kinase 1; Janus Kinase 2; Melanoma; Phosphorylation; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3; Receptors, Histamine H4; Response Elements; RNA, Messenger; Signal Transduction; Skin Neoplasms; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Tyrosine | 2002 |
Tyrosine-nitration of caspase 3 and cytochrome c does not suppress apoptosis induction in squamous cell carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Survival; Cytochrome c Group; Enzyme Activation; Enzyme Precursors; HeLa Cells; Humans; Mouth Neoplasms; Nitric Oxide; Nitric Oxide Donors; Nitrosation; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Precipitin Tests; Superoxides; Tumor Cells, Cultured; Tyrosine | 2003 |
L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Protein Biosynthesis; Radiopharmaceuticals; Tomography, Emission-Computed; Tyrosine | 2003 |
Transmodulation between phospholipase D and c-Src enhances cell proliferation.
Topics: Animals; Carcinoma, Squamous Cell; Catalytic Domain; Cell Division; Cells, Cultured; CSK Tyrosine-Protein Kinase; Cytoskeletal Proteins; Enzyme Activation; Epidermal Growth Factor; Female; Humans; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Mutation; Paxillin; Phospholipase D; Phosphoproteins; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Rats; Signal Transduction; src-Family Kinases; Tyrosine | 2003 |
[EGF-induced signal transduction in clonal cells of epidermoid carcinoma A431].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Division; Clone Cells; DNA-Binding Proteins; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Genetic Variation; Humans; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT1 Transcription Factor; Trans-Activators; Transcriptional Activation; Tumor Cells, Cultured; Tyrosine | 2003 |
Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
Topics: 3T3 Cells; Animals; Biosensing Techniques; Carcinoma, Squamous Cell; Cell Division; DNA-Binding Proteins; DNA, Neoplasm; ErbB Receptors; Humans; Kinetics; Mice; Mutation; Peptide Mapping; Phenylalanine; Phosphopeptides; Protein Binding; STAT3 Transcription Factor; Trans-Activators; Transfection; Tumor Cells, Cultured; Tyrosine | 2003 |
Therapy evaluation of laryngeal carcinomas by tyrosine-pet.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Feasibility Studies; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tyrosine | 2003 |
Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China.
Topics: Adult; Amino Acid Substitution; Base Sequence; Carcinoma, Squamous Cell; China; DNA Primers; Epoxide Hydrolases; Esophageal Neoplasms; Female; Genetic Predisposition to Disease; Histidine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Reference Values; Smoking; Tyrosine | 2003 |
Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cadherins; Calcium; Carcinoma, Squamous Cell; Cell Adhesion; Cell Communication; Cell Line, Tumor; Cetuximab; Culture Media, Conditioned; Cytoskeletal Proteins; Desmocollins; Desmoglein 2; Desmogleins; Desmoplakins; Desmosomes; Dose-Response Relationship, Drug; ErbB Receptors; gamma Catenin; Humans; Immunoblotting; Microscopy, Phase-Contrast; Mouth Neoplasms; Phenotype; Phosphorylation; Precipitin Tests; Pyrimidines; Pyrroles; Subcellular Fractions; Tyrosine | 2004 |
Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Topics: beta Catenin; Blotting, Northern; Cadherins; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cytoskeletal Proteins; Epidermal Growth Factor; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Intercellular Junctions; Mouth Neoplasms; Neoplasm Invasiveness; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-met; Signal Transduction; Trans-Activators; Tyrosine | 2004 |
Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Survival Rate; Tyrosine | 2004 |
Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Adenosquamous; Carcinoma, Ductal; Carcinoma, Squamous Cell; Cell Differentiation; Disease Progression; Female; Gene Expression Profiling; Mammary Neoplasms, Experimental; Mice; Oxazoles; PPAR delta; PPAR gamma; Thiazoles; Tyrosine | 2005 |
Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.
Topics: Biopsy; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Erythropoietin; Gene Expression Regulation; Head and Neck Neoplasms; Humans; Hypoxia; Immunohistochemistry; Immunoprecipitation; Janus Kinase 2; Laminin; Models, Statistical; Neoplasm Invasiveness; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Proto-Oncogene Proteins; Receptors, Erythropoietin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tyrosine | 2005 |
WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; In Situ Hybridization; Keratinocytes; Male; Mice; Middle Aged; Oxidoreductases; Phosphorylation; Protein Biosynthesis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Skin Neoplasms; Time Factors; Transfection; Tumor Suppressor Proteins; Tyrosine; Ultraviolet Rays; WW Domain-Containing Oxidoreductase | 2005 |
Collagen XVII promotes integrin-mediated squamous cell carcinoma transmigration--a novel role for alphaIIb integrin and tirofiban.
Topics: Adult; Antineoplastic Agents; Autoantigens; Carcinoma, Squamous Cell; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Chemotaxis; Collagen Type XVII; Epithelium; Humans; Integrin alpha5beta1; Kalinin; Keratinocytes; Neoplasm Invasiveness; Non-Fibrillar Collagens; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Protein Structure, Tertiary; Tirofiban; Tyrosine; Wound Healing | 2006 |
Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Growth Processes; Cornea; Endothelial Cells; Fibroblast Growth Factor 2; Halogenated Diphenyl Ethers; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; NIH 3T3 Cells; Porifera; Rats; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2006 |
[Subunits of human holoenzyme of DNA dependent RNA polymerase III phosphorylated in vivo].
Topics: Carcinoma, Squamous Cell; Catalytic Domain; Cell Line, Tumor; Cell Nucleus; Chromatography, DEAE-Cellulose; Holoenzymes; Humans; Immunoblotting; Molecular Weight; Phosphorylation; Placenta; RNA Polymerase III; Serine; Threonine; Tyrosine | 2005 |
Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cetuximab; Cisplatin; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Head and Neck Neoplasms; Humans; Phosphorylation; Quinazolines; Tyrosine; Tyrphostins | 2006 |
Epidermal growth factor induction of resistance to topoisomerase II toxins in human squamous carcinoma A431 cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Neoplasm; Epidermal Growth Factor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotides; Phosphorylation; Tetrazolium Salts; Thiazoles; Tyrosine | 2006 |
p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism.
Topics: Base Sequence; Carcinoma, Squamous Cell; Catenins; Cell Adhesion Molecules; Cell Line, Tumor; Delta Catenin; DNA Primers; Epidermal Growth Factor; Humans; Neoplasm Invasiveness; Phosphoproteins; Phosphorylation; Recombinant Proteins; RNA, Small Interfering; Tyrosine | 2007 |
EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Fragmentation; Electrophoresis, Agar Gel; Epidermal Growth Factor; Humans; Phosphorylation; RNA, Small Interfering; Signal Transduction; src-Family Kinases; STAT1 Transcription Factor; STAT3 Transcription Factor; Tyrosine | 2007 |
Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility.
Topics: Carcinoma, Squamous Cell; Caspase 8; Cell Adhesion; Cell Line, Tumor; Cell Movement; Humans; Phosphatidylinositol 3-Kinases; Protein Subunits; Proto-Oncogene Proteins c-akt; src Homology Domains; Tyrosine | 2007 |
Hypercoagulability due to homocystinuria in a case of head and neck reconstruction resolved with combined systemic therapy.
Topics: Carcinoma, Squamous Cell; Fibrinolytic Agents; Head and Neck Neoplasms; Homocystinuria; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Surgical Flaps; Thrombophilia; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 2008 |
The kinetics of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A-431 cells.
Topics: Carcinoma, Squamous Cell; Cell Line; Cell Membrane; ErbB Receptors; Humans; Kinetics; Phosphorylation; Protein Kinases; Receptors, Cell Surface; Tyrosine | 1983 |
Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.
Topics: Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Chromatography, Thin Layer; Electrophoresis, Paper; Enzyme Activation; Epidermal Growth Factor; Humans; Membrane Proteins; Peptides; Phosphotyrosine; Protein Kinases; Tyrosine | 1980 |
Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn.
Topics: Carcinoma, Squamous Cell; Cations, Divalent; Cell Line; Cell Membrane; Humans; Kinetics; Membrane Proteins; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Tyrosine; Zinc | 1981 |
Human cells contain two forms of pp60c-src.
Topics: Carcinoma, Squamous Cell; Fibroblasts; Humans; Molecular Weight; Neoplasm Proteins; Oncogene Protein pp60(v-src); Peptide Fragments; Phosphoproteins; Phosphotyrosine; Tyrosine; Viral Proteins | 1981 |
Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes.
Topics: Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Epidermal Growth Factor; Oncogene Protein pp60(v-src); Peptide Fragments; Phosphoproteins; Phosphotyrosine; Protein Kinases; Tyrosine; Viral Proteins | 1982 |
Purification of the receptor for epidermal growth factor from A-431 cells: its function as a tyrosyl kinase.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Epidermal Growth Factor; ErbB Receptors; Humans; Mice; Molecular Weight; Phosphorus Radioisotopes; Phosphorylation; Phosphotyrosine; Protein Kinases; Protein-Tyrosine Kinases; Radioisotope Dilution Technique; Receptors, Cell Surface; Tyrosine | 1983 |
Epidermal growth factor stimulates tyrosine phosphorylation of the myosin regulatory light chain from smooth muscle.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Chickens; Epidermal Growth Factor; ErbB Receptors; Gizzard, Avian; Humans; Kinetics; Muscle, Smooth; Myosins; Phosphorylation; Protein Kinases; Receptors, Cell Surface; Tyrosine | 1983 |
Phorbol esters potentiate tyrosine phosphorylation of epidermal growth factor receptors in A431 membranes by a calcium-independent mechanism.
Topics: Adenosine Triphosphate; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Molecular Weight; Peptide Fragments; Phorbols; Phosphorus Radioisotopes; Phosphorylation; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Tyrosine | 1984 |
Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
Topics: Amino Acids; Carcinogens; Carcinoma, Squamous Cell; Cell Line; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Phorbol Esters; Phorbols; Phosphorylation; Protein Kinase C; Protein Kinases; Receptors, Cell Surface; Tyrosine | 1984 |
Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; Cells, Cultured; Epidermal Growth Factor; Humans; Kinetics; Melanoma; Membrane Proteins; Mice; Peptides; Phosphorylation; Transforming Growth Factors; Tyrosine | 1982 |
GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Dogs; ErbB Receptors; Erythrocytes; G(M3) Ganglioside; Humans; Kinetics; Macromolecular Substances; Phosphorylation; Phosphoserine; Phosphothreonine; Phosphotyrosine; Serine; Tumor Cells, Cultured; Tyrosine | 1994 |
Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung.
Topics: Adenocarcinoma; Amino Acid Sequence; Antibodies; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Casein Kinases; Caseins; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Humans; Kinetics; Lung; Lung Neoplasms; Molecular Sequence Data; Myelin Basic Protein; Peptides; Phosphoserine; Phosphothreonine; Phosphotyrosine; Protein Kinases; Protein Serine-Threonine Kinases; Ribosomal Protein S6; Ribosomal Proteins; Substrate Specificity; Tyrosine | 1994 |
Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells.
Topics: Benzoquinones; Carcinoma, Squamous Cell; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Integrins; Lactams, Macrocyclic; Mouth Neoplasms; Neoplasm Invasiveness; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-met; Quinones; Receptor Protein-Tyrosine Kinases; Rifabutin; Tumor Cells, Cultured; Tyrosine | 1994 |
Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line.
Topics: alpha Catenin; Benzoquinones; beta Catenin; Cadherins; Carcinoma, Squamous Cell; Cell Adhesion; Cell Aggregation; Cell Line; Culture Techniques; Cytoskeletal Proteins; Epidermal Growth Factor; ErbB Receptors; Esophageal Neoplasms; Fibroblasts; Fluorescent Antibody Technique; Gels; Humans; Lactams, Macrocyclic; Neoplasm Invasiveness; Neoplasm Proteins; Phenotype; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Quinones; Rifabutin; Signal Transduction; Trans-Activators; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrosine; Vanadates | 1995 |
[The expression of C-FOS, C-JUN and phosphotyrosine gene products in lung cancer].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Gene Expression; Humans; Lung Neoplasms; Phosphotyrosine; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Tyrosine | 1994 |
Increased adherence of Escherichia coli RDEC-1 to human tissue culture cells results in the activation of host signaling pathways.
Topics: Actinin; Animals; Bacterial Adhesion; Carcinoma, Squamous Cell; Cell Line; Cell Line, Transformed; Diarrhea; Epithelium; Escherichia coli; Escherichia coli Infections; Fluorescent Antibody Technique; Humans; Intestines; Phosphotyrosine; Plasmids; Rabbits; Signal Transduction; Species Specificity; Tumor Cells, Cultured; Tyrosine | 1995 |
Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells.
Topics: Actins; Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cytochalasin D; Epidermal Growth Factor; Humans; Intercellular Junctions; Membrane Proteins; Phosphoproteins; Phosphorylation; Phosphotyrosine; Tumor Cells, Cultured; Tyrosine; Zonula Occludens-1 Protein | 1995 |
Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Carcinoma, Squamous Cell; Cardiotonic Agents; Catechols; Cell Communication; Cell Line; Cell Line, Transformed; Cytoskeleton; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Genes, src; Humans; Immunoblotting; Lung Neoplasms; Mice; Nitriles; Phosphoproteins; Phosphotyrosine; Protein-Tyrosine Kinases; Pyrazines; Quinolines; Tubulin; Tumor Cells, Cultured; Tyrosine; Tyrphostins; Vimentin | 1995 |
Ligand-dependent and -independent activation of the transcription factor gamma RF-1 in a cell-free system.
Topics: Adenosine Triphosphate; Antibodies; Base Sequence; Carcinoma, Squamous Cell; Cell Line; Cell-Free System; Cytosol; Humans; Interferon-gamma; Kinetics; Leukemia, Myeloid; Ligands; Molecular Sequence Data; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; Repetitive Sequences, Nucleic Acid; Skin Neoplasms; Transcription Factors; Tumor Cells, Cultured; Tyrosine; Vanadates | 1995 |
Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family.
Topics: Amino Acid Sequence; Animals; Antibodies; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Humans; Isoenzymes; Kidney Neoplasms; Molecular Sequence Data; Molecular Weight; Phosphotyrosine; Protein Kinases; Protein-Tyrosine Kinases; Proteins; Rats; Signal Transduction; Tumor Cells, Cultured; Tyrosine; Wilms Tumor | 1993 |
Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Division; ErbB Receptors; Evaluation Studies as Topic; Head and Neck Neoplasms; Humans; Keratinocytes; Ligands; Neoplasm Proteins; Phosphorylation; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tyrosine | 1995 |
[The correlation between epidermal growth factor (EGF) binding with receptors and the tyrosine phosphorylation of the EGF receptors in the plasma membrane and in the endosomes].
Topics: Carcinoma, Squamous Cell; Cell Membrane; Endosomes; Epidermal Growth Factor; ErbB Receptors; Humans; Iodine Radioisotopes; Ligands; Membrane Proteins; Phosphorylation; Precipitin Tests; Protein Binding; Tumor Cells, Cultured; Tyrosine | 1994 |
Tumor promoter phorbol ester reversibly modulates tyrosine dephosphorylation/inactivation of protein kinase FA/GSK-3 alpha in A431 cells.
Topics: Amino Acid Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; Carcinoma, Squamous Cell; Enzyme Activation; Glycogen Synthase Kinase 3; Humans; Molecular Sequence Data; Phorbol Esters; Phosphorylation; Precipitin Tests; Protein Kinase C; Protein Kinases; Signal Transduction; Tumor Cells, Cultured; Tyrosine | 1994 |
Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
Topics: beta Catenin; Cadherins; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Cell Size; Collagen; Cytoskeletal Proteins; Detergents; Epidermal Growth Factor; ErbB Receptors; Humans; Octoxynol; Phosphorylation; Skin Neoplasms; Solubility; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 1996 |
Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tyrosine | 1996 |
Correlation of constitutive activation of raf-1 with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cloning, Molecular; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Phosphoproteins; Phosphorylation; Plasmids; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Transfection; Tumor Cells, Cultured; Tyrosine | 1997 |
[Dynamics of EGF-induced nuclear-cytoplasmic transport of transcription factor STAT1 in A431 cells].
Topics: Acetates; Binding Sites; Biological Transport; Blotting, Western; Buffers; Carcinoma, Squamous Cell; Cell Nucleus; Cytoplasm; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Epidermal Growth Factor; Humans; Hydrogen-Ion Concentration; Microscopy, Fluorescence; Phosphorylation; Signal Transduction; STAT1 Transcription Factor; Trans-Activators; Tyrosine | 1997 |
Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Substitution; Animals; Brain; Carcinoma, Squamous Cell; Cattle; Cell Line, Transformed; ErbB Receptors; Glutathione Transferase; Humans; Mice; Mutagenesis, Site-Directed; Oncogene Protein pp60(v-src); Phosphatidylinositol 4,5-Diphosphate; Protein Kinases; Proteins; Proto-Oncogene Proteins pp60(c-src); Recombinant Fusion Proteins; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Tumor Cells, Cultured; Tyrosine | 1997 |
Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.
Topics: Antibodies; Antibody Specificity; Carcinoma, Squamous Cell; Dimerization; Down-Regulation; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Humans; Immunoblotting; Ligands; Phosphorylation; Precipitin Tests; Receptor, ErbB-2; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 1997 |
Melanin-concentrating hormone binding sites in human SVK14 keratinocytes.
Topics: Amino Acid Sequence; Animals; Binding Sites; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Membrane; Humans; Hypothalamic Hormones; Iodine Radioisotopes; Keratinocytes; Melanins; Melanoma; Molecular Sequence Data; Neuroglia; PC12 Cells; Phenylalanine; Pituitary Hormones; Radioligand Assay; Rats; Receptors, Pituitary Hormone; Tumor Cells, Cultured; Tyrosine | 1997 |
The naturally occurring PKC inhibitor sphingosine and tumor promoter phorbol ester potentially induce tyrosine phosphorylation/activation of oncogenic proline-directed protein kinase FA/GSK-3alpha in a common signalling pathway.
Topics: Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; Carcinoma, Squamous Cell; Enzyme Activation; Enzyme Induction; Genistein; Glycogen Synthase Kinase 3; Humans; Phosphorylation; Phosphotyrosine; Protein Kinase C; Signal Transduction; Sphingosine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine | 1998 |
EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
Topics: Antibodies, Monoclonal; Apoptosis; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Enzyme Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Humans; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Tumor Cells, Cultured; Tyrosine | 1998 |
Detection of oral dysplasia in animals with fluorine-18-FDG and carbon-11-tyrosine.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carbon Radioisotopes; Carcinogens; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Mouth Mucosa; Mouth Neoplasms; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, Emission-Computed; Tyrosine | 1998 |
A novel variant of human Grb7 is associated with invasive esophageal carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Alternative Splicing; Amino Acid Sequence; Base Sequence; Carcinoma, Squamous Cell; Cell Movement; ErbB Receptors; Esophageal Neoplasms; GRB2 Adaptor Protein; GRB7 Adaptor Protein; Humans; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Proteins; RNA, Antisense; Sequence Homology, Amino Acid; Signal Transduction; src Homology Domains; Tumor Cells, Cultured; Tyrosine | 1998 |
Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas.
Topics: Adenocarcinoma; alpha Catenin; beta Catenin; Cadherins; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cytoskeletal Proteins; Down-Regulation; Humans; Lung Neoplasms; Macromolecular Substances; Neoplasm Invasiveness; Phosphorylation; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 1998 |
Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole.
Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Squamous Cell; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Cell-Free System; Cyclin B; Cyclin B1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mitosis; Nocodazole; Phosphoprotein Phosphatases; Phosphorylation; Proteins; Skin Neoplasms; Staurosporine; Tumor Cells, Cultured; Tyrosine | 1999 |
Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell dea
Topics: Antibodies; Breast Neoplasms; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma; Carcinoma, Squamous Cell; Cell Death; Cell Division; DNA, Antisense; Dose-Response Relationship, Radiation; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Nitriles; Phosphorylation; Protein Kinases; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 1999 |
In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action.
Topics: 3T3 Cells; Adjuvants, Immunologic; Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Crotonates; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Glioma; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitriles; Phosphorylation; Pyrimidine Nucleotides; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Toluidines; Tumor Cells, Cultured; Tyrosine | 1999 |
Comparative study of the effects of polyunsaturated fatty acids and their metabolites on cell growth and tyrosine kinase activity in oesophageal carcinoma cells.
Topics: Animals; Arachidonic Acid; Carcinoma, Squamous Cell; Cell Division; Cell Line; Chlorocebus aethiops; Dinoprostone; Esophageal Neoplasms; Fatty Acids, Unsaturated; Flow Cytometry; gamma-Linolenic Acid; Humans; Kidney; Phosphorylation; Prostaglandins A; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine | 1999 |
Increased protein nitrosylation in head and neck squamous cell carcinogenesis.
Topics: Adult; Analysis of Variance; Carcinoma, Squamous Cell; Culture Techniques; Disease Progression; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Proteins; Nitric Oxide; Reference Values; Staining and Labeling; Statistics, Nonparametric; Tyrosine | 2000 |
Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nitric Oxide; Tumor Suppressor Protein p53; Tyrosine | 2000 |
Glutathione S-transferase pi in squamous cell carcinoma of the head and neck.
Topics: Adult; Carcinoma, Squamous Cell; Glutathione S-Transferase pi; Glutathione Transferase; Head and Neck Neoplasms; Humans; Immunohistochemistry; Isoenzymes; Middle Aged; Mouth Mucosa; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Tyrosine; Up-Regulation | 2000 |
Differential tyrosine phosphorylation of phospholipase D isozymes by hydrogen peroxide and the epidermal growth factor in A431 epidermoid carcinoma cells.
Topics: Carcinoma, Squamous Cell; Catalase; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Hydrogen Peroxide; Isoenzymes; Oxidants; Phospholipase D; Phosphorylation; Protein Kinase C; Protein Kinase C-alpha; Tumor Cells, Cultured; Tyrosine | 2001 |
Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor.
Topics: Antibiotics, Antineoplastic; Bacterial Proteins; Carcinoma, Squamous Cell; Catalase; Cell Division; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Glycoproteins; Growth Inhibitors; GTP-Binding Proteins; Humans; MAP Kinase Signaling System; Pertussis Toxin; Phosphorylation; Precipitin Tests; Protein Tyrosine Phosphatases; Tumor Cells, Cultured; Tyrosine; Vanadates; Virulence Factors, Bordetella | 2001 |
Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers.
Topics: Animals; Carcinoma, Squamous Cell; Carrier Proteins; CDC2-CDC28 Kinases; Cell Cycle Proteins; Chromosomes, Human, Pair 18; Colonic Neoplasms; COS Cells; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclins; DNA, Complementary; Growth Inhibitors; Head and Neck Neoplasms; HeLa Cells; Humans; In Situ Hybridization, Fluorescence; Mice; Nuclear Proteins; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Transfection; Tyrosine | 2001 |
Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; China; Chronic Disease; Codon; Codon, Nonsense; CpG Islands; Cyclooxygenase 2; DNA Mutational Analysis; DNA, Neoplasm; Esophageal Neoplasms; Esophagitis; Europe; Exons; Female; Frameshift Mutation; Genes, p53; Humans; Incidence; Iran; Isoenzymes; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Nitric Oxide; Point Mutation; Prostaglandin-Endoperoxide Synthases; Risk Factors; Sequence Analysis, DNA; Tyrosine | 2001 |
Retention of epidermal growth factor receptors in the endoplasmic reticulum of adenovirus-infected cells.
Topics: Adenoviruses, Human; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Membrane; Down-Regulation; Endoplasmic Reticulum; ErbB Receptors; Histocompatibility Antigens Class I; Humans; KB Cells; Kinetics; Oligosaccharides; Phosphotyrosine; Receptors, Transferrin; Time Factors; Tyrosine | 1992 |
Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
Topics: Annexins; Calcium; Calcium-Binding Proteins; Carcinoma, Squamous Cell; Cell Division; Cytoplasm; Drug Tolerance; Epidermal Growth Factor; ErbB Receptors; Humans; Mutation; Phosphorylation; Phosphotyrosine; Tumor Cells, Cultured; Tyrosine | 1990 |
Functional state of the epidermal growth factor-receptor complexes during their internalization in A-431 cells.
Topics: Biological Transport; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Epidermal Growth Factor; ErbB Receptors; Humans; Phosphotyrosine; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tyrosine | 1990 |
[The immunofluorescent detection of phosphorylated receptors of the epidermal growth factor during their internalization in A-431 cells].
Topics: Carcinoma, Squamous Cell; Cell Line; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody Technique; Humans; Hydrogen-Ion Concentration; Phosphorylation; Phosphotyrosine; Staining and Labeling; Temperature; Tumor Cells, Cultured; Tyrosine | 1990 |
Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
Topics: Amino Acid Sequence; Binding Sites; Carcinoma, Squamous Cell; Cell Membrane; Endothelial Growth Factors; Endothelium, Vascular; Humans; In Vitro Techniques; Lymphokines; Molecular Sequence Data; Molecular Weight; Phosphoproteins; Phosphotyrosine; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Temperature; Time Factors; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1991 |
[The direct demonstration of the tyrosine phosphorylation of epidermal growth factor receptors internalized in the endosomes of A431 cells].
Topics: Antibodies; Carcinoma, Squamous Cell; Cell Fractionation; Cell Line; Epidermal Growth Factor; ErbB Receptors; Humans; Immunohistochemistry; Organelles; Phosphorylation; Phosphotyrosine; Tumor Cells, Cultured; Tyrosine | 1991 |
Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action.
Topics: Autoradiography; Blotting, Western; Carcinoma, Squamous Cell; Ceramides; Chromatography, High Pressure Liquid; Epidermal Growth Factor; Humans; Peptide Mapping; Phosphorylation; Signal Transduction; Sphingosine; Tumor Cells, Cultured; Tyrosine | 1991 |
Phosphonic and phosphinic acid analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) as potential antimelanotic agents.
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Dihydroxyphenylalanine; Humans; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Mouth Neoplasms; Neoplasm Proteins; Organophosphonates; Phosphinic Acids; Tumor Cells, Cultured; Tyrosine | 1990 |
Reduced tyrosine phosphorylation and nonresponsiveness to EGF-mediated cytotoxicity in EGF receptor-hyperproducing UCVA-1 cells.
Topics: Carcinoma, Squamous Cell; Cell Division; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Humans; Pancreatic Neoplasms; Peptide Mapping; Phosphatidylinositols; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine | 1990 |
Relationship between production of epidermal growth factor receptors, gene amplification, and chromosome 7 translocation in variant A431 cells.
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; Chromosomes, Human, 6-12 and X; Clone Cells; Epidermal Growth Factor; ErbB Receptors; Gene Amplification; Humans; Neoplasm Proteins; Phosphoproteins; Phosphotyrosine; Receptors, Cell Surface; RNA, Messenger; RNA, Neoplasm; Translocation, Genetic; Tyrosine | 1985 |
Association of the epidermal growth factor receptor kinase with the detergent-insoluble cytoskeleton of A431 cells.
Topics: Carcinoma, Squamous Cell; Cell Line; Cytoskeleton; Epidermal Growth Factor; ErbB Receptors; Humans; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Cell Surface; Tyrosine | 1985 |
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
Topics: Amino Acids; Animals; Carcinoma, Squamous Cell; Cattle; Cell Division; Cell Line; Depression, Chemical; Dogs; Epidermal Growth Factor; ErbB Receptors; Female; Fibroblasts; G(M1) Ganglioside; G(M3) Ganglioside; Gangliosides; Humans; Immunosorbent Techniques; Mice; Mouth Neoplasms; Ovarian Neoplasms; Phosphorylation; Phosphotyrosine; Receptors, Cell Surface; Tyrosine | 1986 |
Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.
Topics: Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Viral; Enzyme Activation; ErbB Receptors; Growth Substances; Humans; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Tyrosine; Vaccinia virus; Viral Proteins | 1986 |
Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell.
Topics: Carcinoma, Squamous Cell; Cell Line; Epidermal Growth Factor; ErbB Receptors; Humans; Immunosorbent Techniques; Insulin; Insulin-Like Growth Factor I; Molecular Weight; Phosphorylation; Phosphotyrosine; Proteins; Receptor, Insulin; Receptors, Somatomedin; Somatomedins; Tyrosine | 1987 |
Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells.
Topics: Antibodies; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Cytosol; Epidermal Growth Factor; Hydrolysis; Inositol Phosphates; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Substrate Specificity; Tumor Cells, Cultured; Type C Phospholipases; Tyrosine | 1988 |
Purification of the epidermal growth factor receptor by tyrosine-Sepharose affinity chromatography.
Topics: Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Chromatography, Affinity; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Humans; Kinetics; Phosphorylation; Receptors, Cell Surface; Sepharose; Tyrosine | 1985 |
Kinetics and regulation of the tyrosine phosphorylation of epidermal growth factor receptor in intact A431 cells.
Topics: Carcinoma, Squamous Cell; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Fibroblasts; Humans; Hydrogen-Ion Concentration; Immunoassay; Kinetics; Phosphorylation; Protein Kinase C; Trypsin; Tumor Cells, Cultured; Tyrosine | 1988 |
Actinic keratoses in Bantu albinos. Clinical experiences with the topical use of 5-fluoro-uracil.
Topics: Adult; Albinism; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Catechol Oxidase; Child; Female; Fluorouracil; Humans; Keratosis; Male; Middle Aged; Ointments; Skin Neoplasms; Sunlight; Tyrosine | 1973 |
Intracellular degradation of the Guerin tumor proteins in rats.
Topics: Animals; Arginine; Carcinoma, Squamous Cell; Cathepsins; Cells, Cultured; Cytoplasm; Liver; Microsomes; Neoplasm Proteins; Neoplasms, Experimental; Peptide Hydrolases; Rats; Subcellular Fractions; Tyrosine | 1974 |
[On phenylketonuria with normal intelligence].
Topics: Aged; Carcinoma, Squamous Cell; Diet Therapy; Humans; Intelligence; Male; Mental Disorders; Phenylalanine; Phenylketonurias; Phenylpyruvic Acids; Skin Neoplasms; Tyrosine | 1969 |